Eldecalcitol Inhibitor

Eldecalcitol possesses a potent inhibitory effect on bone resorption and induces a significant increase in bone mineral density. Eldecalcitol is an orally active analogue of active vitamin D. It also is used in the treatment,of osteoporosis.

Matsumoto T.Osteoporosis treatment,by a New Active Vitamin D3 Compound, Eldecalcitol, in Japan.Curr Osteoporos Rep. 2012 Aug 24.
Matsumoto T.Osteoporosis treatment,by a New Active Vitamin D3 Compound, Eldecalcitol, in Japan.Curr Osteoporos Rep. 2012 Aug 24.
Shiraki M, et al. Eldecalcitol normalizes bone turnover markers regardless of their pre-treatment,levels.Curr Med Res Opin. 2012 Aug 23.
Shiraki M, et al. Eldecalcitol normalizes bone turnover markers regardless of their pre-treatment,levels.Curr Med Res Opin. 2012 Aug 23.
Matsumoto T, Endo I.Eldecalcitol for the treatment,of osteoporosis.Drugs Today (Barc). 2012 Mar;48(3):189-96.
Matsumoto T, Endo I.Eldecalcitol for the treatment,of osteoporosis.Drugs Today (Barc). 2012 Mar;48(3):189-96.
Sakai S, et al.Combination therapy with eldecalcitol and alendronate has therapeutic advantages over monotherapy by improving bone strength. Bone. 2012 May;50(5):1054-63. Epub 2012 Feb 17.
Sakai S, et al.Combination therapy with eldecalcitol and alendronate has therapeutic advantages over monotherapy by improving bone strength. Bone. 2012 May;50(5):1054-63. Epub 2012 Feb 17.
Sanford M, McCormack PL.Spotlight on eldecalcitol in osteoporosis.Drugs Aging. 2012 Jan 1;29(1):69-71.
Sanford M, McCormack PL.Spotlight on eldecalcitol in osteoporosis.Drugs Aging. 2012 Jan 1;29(1):69-71.

Small volumes of Eldecalcitol, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS5754822 is an inhibitor targeting Eldecalcitol.